Testing effectiveness (Phase 2)Study completedNCT01486446
What this trial is testing
Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
Who this might be right for
Primary ErythromelalgiaInherited Erythromelalgia
Xenon Pharmaceuticals Inc. 8